Show notes
This episode is sponsored by BONESUPPORT™, maker of CERAMENT® G with Gentamicin – the one and only FDA authorized, antibiotic-eluting bone void filler. For more information, visit https://www.bonesupport.com/en-us/products/cerament-g/
Paul Matuszewski, MD, from University of Kentucky is joined by Chris Cosgrove, MD and Peter Everson, MD to discuss how they're using new technology and evidence to best care for their patients in today's cost-conscious landscape. Over the course of forty minutes, they discuss their move towards single-stage surgeries, shortened antibiotic treatment regimens, and how they're even treating some of their patients outpatient with CERAMENT G. They also discuss the new CMS ruling for FY2027 and what it means for CERAMENT G.
Interested in staying in touch? Follow BONESUPPORT on LinkedIn https://www.linkedin.com/company/bonesupport-ab/
References discussed in this episode:
· Conway J, et al. 'Antibiotic Cement-Coated Rods.' Bone Joint J. vol. 96-B, no. 10, 2014, pp. 1349-1354. doi:10.1302/0301-620X.96B10.33799.
· McNally et al. 'Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases.' Bone Joint J. 2016;98-B(9):1289-96
· Godina M. Early microsurgical reconstruction of complex trauma of the extremities. Plast Reconstr Surg. 1986;78(3):285-292. doi:10.1097/00006534-198609000-00001
· McNally et al. 'Mid- to long-term results of single-stage surgery for patients with chronic osteomyelitis using a bioabsorbable gentamicin-loaded ceramic carrier.' Bone Joint J. 2022;104-B(9):1095-1100.
· Ferguson J et al., 'A Comparison of Clinical and Radiological Outcomes between Two Different Biodegradable Local Antibiotic Carriers Used in the Single- stage Surgical Management of Long Bone Osteomyelitis', Bone & Joint Research, 2023; 12(7): 412–22
· Henry et al., 'Long-Term Follow-Up of Open Gustilo-Anderson IIIB Fractures Treated With an Adjuvant Local Antibiotic Hydroxyapatite Bio-Composite', Cureus. 2023; 15(5).
· Li et al. 'Oral versus Intravenous Antibiotics for Bone and Joint Infection.' The New England Journal of Medicine, 2019; 380:425-436
· Major Extremity Trauma Research Consortium (METRC). 'Oral vs intravenous antibiotics for fracture-related infections: the POvIV randomized clinical trial.' JAMA Surg. 2025;160(3):276-284.
Information discussed regarding CMS:
· Centers for Medicare & Medicaid Services (US). Medicare program; hospital inpatient prospective payment systems for acute care hospitals (IPPS) and the long-term care hospital prospective payment system and policy changes and fiscal year (FY) 2027 rates; requirements for quality programs; other policy changes; and adoption of updated versions of certain health information technology standards. Final rule (CMS-1849-F) [Internet]. Fed Regist. 2026 Aug 4 [cited 2026 Aug 20]. Available from: https://www.federalregister.gov/documents/2026/08/04/2026-15833/medicare-program-hospital-inpatient…. Also available from: https://www.govinfo.gov/content/pkg/FR-2026-08-04/pdf/2026-15833.pdf
Our TOPPODCAST Picks 
Stay Connected
